Virtual Reality Software to Reduce Stress in Cancer Patients

NCT ID: NCT05263648

Last Updated: 2024-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-30

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the ability of virtual reality-based social support to increase patient adherence to radiation therapy by reducing patient distress.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will involve patients who have been diagnosed with breast or head and neck cancer and are suitable to receive radiation therapy. It is a single arm pilot trial designed to provide information on the safety, feasibility, and impacts of incorporating virtual reality (VR) software into the treatment plan of patients receiving radiation therapy with the goal of increasing patient adherence to radiation therapy.

Patients will be provided with VR-based education sessions prior to and during the course of radiation therapy. Patients' emotional and social distress levels will be assessed with questionnaires to measure the impacts of the VR software. Patients will be in the study for up to 3 months during regular cancer care, but the total time for the study procedures is anticipated to be 2-4 hours in total. Results from this study will be for research only and will not impact treatment decisions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Head and Neck Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual Reality Sessions

Patients will undergo at least two VR sessions. One prior to and one during the course of radiation treatment.

Group Type OTHER

Virtual Reality Session

Intervention Type OTHER

VR-based education sessions will be used to influence patients' perceived emotional and social distress while undergoing radiation therapy (RT).

Emotional and social distress levels will be evaluated using questionnaires at baseline (prior to the first VR experience), at completion of RT, and at 30-60 days post RT.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Reality Session

VR-based education sessions will be used to influence patients' perceived emotional and social distress while undergoing radiation therapy (RT).

Emotional and social distress levels will be evaluated using questionnaires at baseline (prior to the first VR experience), at completion of RT, and at 30-60 days post RT.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥ 18 years old
2. Must be able to read and speak English
3. Diagnosis of breast or head and neck cancer
4. Treatment plan includes radiotherapy within the next 2 months
5. Signed study-specific informed consent prior to study entry

Exclusion Criteria

1. Previous radiation therapy treatment
2. Neurologic deficits
3. Visual disorder
4. Neuro-psychiatric disorder
5. Use of neuro-psychiatric drugs
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oklahoma

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christina Henson, MD

Role: PRINCIPAL_INVESTIGATOR

Stephenson Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OU-SCC-Virtual Reality

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rehabilitation for People With Advanced Cancer
NCT05424068 ACTIVE_NOT_RECRUITING NA
Virtual Vs Telephone Education in Radiotherapy
NCT07255196 NOT_YET_RECRUITING NA